Trial shows sodium bicarbonate improved performance in CrossFit athletes, suggesting enhanced buffering capacity may benefit high-intensity exercise.
Purpose: This study compared the ingestion of a matched dose (0.3 g·kg −1 BM) of enteric-coated sodium bicarbonate (SB), sodium citrate (SC), and both combined (SBC) on high-intensity exercise performance using a time-to-peak ingestion strategy. Methods: Ten trained female CrossFit athletes completed four 6-km cycling time trials after consuming either SB, SC, SBC, or a placebo (PLA) in enteric-coated capsules. Blood acid–base balance was measured preingestion, preexercise, and postexercise. Results: Preexercise blood was significantly higher in the SB trial compared with the SC (+2.3 [1.8] mmol·L −1 , P = .003, g = 1.2) and PLA (+6.5 [1.1 mmol·L −1 , P < .0005, g = 2.5) trial. Performance time was faster with SB trials when compared with SC (−11.6 [8.0] s, P = .01), SBC (−17.2 [9.1] s, P = .001), and PLA (−21.5 [14.5] s, P = .007), with no significant difference between SC (mean difference [MD] = 9.9 s, P = .94) and SBC (MD = 4.3, P = 1.0) when compared with PLA. Blood lactate concentration was significantly greater in the SB trial compared with the placebo (MD = 2.4 [2.8] mmol·L −1 , P < .001). Preexercise gastrointestinal symptom scores were higher with SB when compared to PLA (MD = 2.4 [3.2] arbitrary units, P = .04) and SC (MD = 2.2 [2.7], P = .032). Conclusion: Ingestion of 0.3 g·kg −1 BM of SB improved extracellular buffering capacity when compared with SC and PLA, allowing exercise performance improvements.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: